APA (7th ed.) Citation

Jansa, P., Kopeć, G., Torbicki, A., Sadushi-Kolici, R., Campean, I., Halank, M., . . . Lang, I. M. (2023). The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil. Pulmonary Circulation, 13(3), 1. https://doi.org/10.1002/pul2.12274

Chicago Style (17th ed.) Citation

Jansa, Pavel, et al. "The Risk Profile Change in Patients with Severe Chronic Thromboembolic Pulmonary Hypertension Treated with Subcutaneous Treprostinil." Pulmonary Circulation 13, no. 3 (2023): 1. https://doi.org/10.1002/pul2.12274.

MLA (9th ed.) Citation

Jansa, Pavel, et al. "The Risk Profile Change in Patients with Severe Chronic Thromboembolic Pulmonary Hypertension Treated with Subcutaneous Treprostinil." Pulmonary Circulation, vol. 13, no. 3, 2023, p. 1, https://doi.org/10.1002/pul2.12274.